Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost and dorzolamide for pediatric glaucoma refractory to surgery
2008-004763-19Phase 2Completed
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of latanoprost and dorzolamide in primary congenital glaucoma (PCG) and Buphthalmos (CG), sponsored by ASST Spedali Civili di Brescia. Started Apr 2009; status: completed.
02
Drugs
latanoprostdorzolamide
03
Conditions
primary congenital glaucoma (PCG)Buphthalmos (CG)
Beyond the preview
Go deeper on 2008-004763-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004763-19.